Photonics promises to revolutionise health monitoring. Here, Tom Watson explores the wider potential in personalised medicine – and provides insight into overcoming the key challenges that lie ahead.
The current state of in vitro diagnostics (IVDs) is no longer fit for purpose. In vitro diagnostics needs seismic change to improve patient outcomes and deliver economic benefits.
To decentralise, or not to decentralise, that is the question. This Web3 dilemma reflects the likely thoughts of current digital leaders who want to make the best use of their digital assets while maintaining trust in their data systems.
Cell and gene therapy is hailed as the future of 21st century medicine but is currently too expensive to be widely used. As a principal scientist in synthetic biology, Matthew Jones is part of a team addressing this issue in an ambitious project with exciting potential.
This whitepaper goes behind the scenes of a significant breakthrough for contamination detection in cell therapy monitoring. It tells the story of PureSentry, a prototype device for on-line, real-time detection.
People with diabetes have an increased risk of developing serious health problems, including neuropathy. We’ve developed an AI-based system, in partnership with eminent specialists, to assess the presence of neuropathy from retinal images.